ABN.AS: $40.75 ▲ 0.30 (0.74%)DSFIR.AS: $99.66 ▼ -0.99 (-0.98%)GMAB.CO: $2,487.00 ▲ 42.00 (1.72%)REP.MC: $29.21 ▼ -0.31 (-1.05%)SOON.SW: $267.80 ▲ 3.20 (1.21%)CRWD: $263.01 ▼ -12.03 (-4.37%)HPE: $70.30 ▼ -3.16 (-4.30%)AMD: $594.24 ▼ -13.86 (-2.28%)DELL: $576.47 ▼ -9.59 (-1.64%)PANW: $403.83 ▼ -14.95 (-3.57%)MRNA: $213.74 ▼ -11.26 (-5.00%)AAPL: $340.97 ▲ 4.33 (1.29%)AMZN: $259.53 ▼ -2.90 (-1.11%)MSFT: $541.15 ▲ 6.08 (1.14%)NVDA: $226.32 ▼ -2.96 (-1.29%)CIEN: $404.86 ▼ -44.91 (-9.99%)DDOG: $287.29 ▼ -5.97 (-2.04%)SNPS: $502.51 ▼ -7.48 (-1.47%)CAP.PA: $115.35 ▲ 0.30 (0.26%)TSCO.L: $511.00 ▲ 7.20 (1.43%)WKL.AS: $77.16 ▲ 2.16 (2.88%)

Company Details

HeartBeam, Inc.

BEAT - NASDAQ

Identifiants & Marche

Ticker BEAT
ISIN US42238H1086
CIK 0001779372
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web Lien

Description

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.